Study Backs Cytokine Targeting for COVID-19 Tx
]]>(MedPage Today) -- Survival rates were significantly higher, though mechanical ventilation-free survival did not differ between hospitalized COVID-19 patients treated with high-dose anakinra (Kineret), an interleukin-1 receptor antagonist, and...
Read more »